Evogene Ltd.
EVGN
$1.05
$0.03933.89%
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.61M | 914.00K | 578.00K | 3.77M | 3.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.61M | 914.00K | 578.00K | 3.77M | 3.77M |
| Cost of Revenue | 755.00K | 537.00K | 398.00K | 511.00K | 511.00K |
| Gross Profit | 856.00K | 377.00K | 180.00K | 3.26M | 3.26M |
| SG&A Expenses | 2.02M | 2.46M | 2.26M | 2.38M | 2.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 500.00K | -- | -- | -- | -- |
| Total Operating Expenses | 6.68M | 7.01M | 8.21M | 7.95M | 7.95M |
| Operating Income | -5.07M | -6.10M | -7.63M | -4.18M | -4.18M |
| Income Before Tax | 2.00K | -5.98M | -7.34M | -3.86M | -3.86M |
| Income Tax Expenses | 7.00K | 1.00K | -4.00K | -5.00K | -5.00K |
| Earnings from Continuing Operations | -5.00K | -5.99M | -7.34M | -3.86M | -3.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 432.00K | 566.00K | 736.00K | -126.00K | -126.00K |
| Net Income | 427.00K | -5.42M | -6.60M | -3.98M | -3.98M |
| EBIT | -5.07M | -6.10M | -7.63M | -4.18M | -4.18M |
| EBITDA | -4.47M | -5.48M | -6.97M | -3.52M | -3.52M |
| EPS Basic | 0.06 | -1.06 | -1.30 | -0.81 | -0.81 |
| Normalized Basic EPS | 0.02 | -0.62 | -0.74 | -0.52 | -0.52 |
| EPS Diluted | 0.06 | -1.06 | -1.30 | -0.81 | -0.81 |
| Normalized Diluted EPS | 0.02 | -0.62 | -0.74 | -0.52 | -0.52 |
| Average Basic Shares Outstanding | 6.80M | 5.09M | 5.06M | 4.89M | 4.89M |
| Average Diluted Shares Outstanding | 6.80M | 5.09M | 5.06M | 4.89M | 4.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
